We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer/BioNTech Evaluate COVID-19 Vaccine in Pregnant Women
Pfizer/BioNTech Evaluate COVID-19 Vaccine in Pregnant Women
Pfizer and BioNTech announced that they have dosed the first patients in a global study evaluating their COVID-19 vaccine in pregnant women 18 years and over.